T1W hyperintenzita bazálních ganglií u neketotické hyperglykemické hemichorey

Stáhnout PDF English version

Autoři: A. Bozer ¹; Y. Pekçevik ^1,2
Působiště autorů: Department of Radiology, Izmir City, Hospital, Izmir, Turkey ¹; Department of Radiology, University, of Health Sciences, Izmir Faculty, of Medicine, Izmir, Turkey ²
Vyšlo v časopise: Cesk Slov Neurol N 2025; 88(2): 121-124
Kategorie: Dopisy redakci
doi: https://doi.org/10.48095/cccsnn2025121

Zdroje

1. Arecco A, Ottaviani S, Boschetti M et al. Diabetic striatopathy: an updated overview of current knowledge and future perspectives. J Endocrinol Invest 2023; 47 (1): 1. doi: 10.1007/S40618-023-02166-5.

2. Chua CB, Sun CK, Hsu CW et al. “Diabetic striatopathy”: clinical presentations, controversy, pathogenesis, treatments, and outcomes. Sci Rep 2020; 10 (1): 1–11. doi: 10.1038/s41598-020-58555-w.

3. Dubey S, Biswas P, Ghosh R et al. Neuroimaging of diabetic striatopathy: more questions than answers. Eur Neurol 2022; 85 (5): 371–376. doi: 10.1159/000524936.

4. Valgaeren B, van Snick E, Hendrickx J. Hyperdense basal ganglia on brain CT in non-ketotic hyperglycemia associated with hemichorea. J Belgian Soc Radiol 2022; 106 (1): 30–31. doi: 10.5334/jbsr.2706.

5. Suárez-Vega VM, Sánchez Almaraz C, Bernardo AI et al. CT and MR unilateral brain features secondary to nonketotic hyperglycemia presenting as hemichorea-hemiballism. Case Rep Radiol 2016; 2016 (1): 1–4. doi: 10.1155/2016/5727138.

6. Lam PL, Iu PP, Cho DHY. Non-ketotic hyperglycaemic hemichorea: a rare complication of uncontrolled diabetes mellitus. Hong Kong Med J 2023; 29 (6): 556.e1–556.e3. doi: 10.12809/hkmj2210290.